| 000 | 03188nam a2200409 i 4500 | ||
|---|---|---|---|
| 999 |
_c112810 _d112810 |
||
| 001 | 112810 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230201171745.0 | ||
| 006 | a||||fo|||| 00| 0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 181227s2019 gw a o |||| 0|eng d | ||
| 020 | _a9783030003623 | ||
| 024 | 7 |
_a10.1007/978-3-030-00362-3 _2doi |
|
| 040 |
_bspa _cES-MaUEC _dES-MaUEC |
||
| 050 | 4 |
_aRB45 _b2019 EB |
|
| 245 | 0 | 0 |
_aAggressive Lymphomas _cedited by Georg Lenz, Gilles Salles |
| 264 | 1 |
_aCham _bSpringer International Publishing : _bImprint: Springer _c2019 |
|
| 300 |
_a1 recurso en línea (VII, 360 páginas) _b70 ilustraciones, 65 ilustraciones a color |
||
| 336 |
_2rdacontent _aTexto _btxt |
||
| 337 |
_2rdamedia _aelectrónico _bc |
||
| 338 |
_2rdacarrier _arecurso electrónico _bcr |
||
| 347 |
_atext file _bPDF |
||
| 490 | 0 |
_aHematologic Malignancies _x2197-9766 |
|
| 490 | 0 | _aMedicine (Springer-11650) | |
| 505 | 0 | _aPART I: Epidemiology, Pathology and molecular Pathogenesis: Epidemiology -- Pathology and molecular pathogenesis of DLBCL and related entities -- Pathology and molecular pathogenesis of Burkitt lymphoma and lymphoblastic lymphoma -- Pathology and molecular pathogenesis of T-cell lymphoma -- Part III: Future directions in aggressive lymphomas: Role of modern imaging in aggressive lymphoma -- Kinase inhibitors -- Immunologic approaches -- Other novel targeted therapies -- How biology will help guiding our treatment decisions?. | |
| 520 | 3 | _aThis book summarizes current knowledge of the biology and molecular pathogenesis of aggressive lymphomas and reviews the state of the art in diagnostic and therapeutic strategies. The aim is both to provide the reader with a sound understanding of the very significant progress that has been achieved in the understanding and management of these malignancies over recent years and to facilitate appropriate choice of the therapeutic strategy in individual cases. The assessment of different prognostic parameters are clearly presented in order to permits effective risk stratification that impacts on treatment choice. Recent insights into lymphomagenesis are exemplified and may assist in identifying emerging therapeutic targets. The comprehensive and up-to-date nature of the book will make it an ideal reference for all physicians and researchers interested in lymphoma, including clinicians from various medical specialties, biologists, pathologists, radiologists and nuclear medicine specialist, as well as students. | |
| 988 | _aSpringer_Medicine_2019 | ||
| 650 | 7 |
_2embne _9168983 _aSangre _xAnálisis |
|
| 700 | 1 |
_aLenz, Georg. _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
| 700 | 1 |
_aSalles, Gilles. _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
| 710 | 2 |
_aSpringerLink (Online service) _9106996 |
|
| 776 | 0 | 8 |
_iPrinted edition: _z9783030003616 |
| 776 | 0 | 8 |
_iPrinted edition: _z9783030003630 |
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-00362-3 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 942 |
_2lcc _cLE |
||
| 998 |
_dz _feng _ggw _h0 _b02/2023 _eb _zSI |
||